The global Adoptive Cell Therapy market was valued at US$ 5.8 billion in 2024 and is projected to reach US$ 14.5 billion by 2030, at a CAGR of 16.5% during the forecast period 2024-2030.
Report Overview
Adoptive cell therapy, also known as cellular immunotherapy, is a form of treatment that uses the cells of our immune system to eliminate cancer.
This report provides a deep insight into the global Adoptive Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adoptive Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adoptive Cell Therapy market in any manner.
Global Adoptive Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Novartis
- Juno
- Kite
- Adaptimmune
- Fibrocell
- Lineage Cell Therapeutics
- BioTime
- Vericel Corporation
- Regeneus
- Anhui Anke Biotechnology
- Cellectis
- NantKwest
- SorrentoTherapeutics
- Bellicum
Market Segmentation (by Type)
Market Segmentation (by Application)
Geographic Segmentation
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adoptive Cell Therapy
1.2 Key Market Segments
1.2.1 Adoptive Cell Therapy Segment by Type
1.2.2 Adoptive Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adoptive Cell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Adoptive Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adoptive Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adoptive Cell Therapy Market Competitive Landscape
3.1 Global Adoptive Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global Adoptive Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adoptive Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adoptive Cell Therapy Sales Sites, Area Served, Product Type
3.6 Adoptive Cell Therapy Market Competitive Situation and Trends
3.6.1 Adoptive Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adoptive Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adoptive Cell Therapy Industry Chain Analysis
4.1 Adoptive Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adoptive Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adoptive Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global Adoptive Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Adoptive Cell Therapy Price by Type (2019-2024)
7 Adoptive Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cell Therapy Market Sales by Application (2019-2024)
7.3 Global Adoptive Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Adoptive Cell Therapy Sales Growth Rate by Application (2019-2024)
8 Adoptive Cell Therapy Market Segmentation by Region
8.1 Global Adoptive Cell Therapy Sales by Region
8.1.1 Global Adoptive Cell Therapy Sales by Region
8.1.2 Global Adoptive Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Adoptive Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adoptive Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adoptive Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adoptive Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adoptive Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Adoptive Cell Therapy Basic Information
9.1.2 Novartis Adoptive Cell Therapy Product Overview
9.1.3 Novartis Adoptive Cell Therapy Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Adoptive Cell Therapy SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Juno
9.2.1 Juno Adoptive Cell Therapy Basic Information
9.2.2 Juno Adoptive Cell Therapy Product Overview
9.2.3 Juno Adoptive Cell Therapy Product Market Performance
9.2.4 Juno Business Overview
9.2.5 Juno Adoptive Cell Therapy SWOT Analysis
9.2.6 Juno Recent Developments
9.3 Kite
9.3.1 Kite Adoptive Cell Therapy Basic Information
9.3.2 Kite Adoptive Cell Therapy Product Overview
9.3.3 Kite Adoptive Cell Therapy Product Market Performance
9.3.4 Kite Adoptive Cell Therapy SWOT Analysis
9.3.5 Kite Business Overview
9.3.6 Kite Recent Developments
9.4 Adaptimmune
9.4.1 Adaptimmune Adoptive Cell Therapy Basic Information
9.4.2 Adaptimmune Adoptive Cell Therapy Product Overview
9.4.3 Adaptimmune Adoptive Cell Therapy Product Market Performance
9.4.4 Adaptimmune Business Overview
9.4.5 Adaptimmune Recent Developments
9.5 Fibrocell
9.5.1 Fibrocell Adoptive Cell Therapy Basic Information
9.5.2 Fibrocell Adoptive Cell Therapy Product Overview
9.5.3 Fibrocell Adoptive Cell Therapy Product Market Performance
9.5.4 Fibrocell Business Overview
9.5.5 Fibrocell Recent Developments
9.6 Lineage Cell Therapeutics
9.6.1 Lineage Cell Therapeutics Adoptive Cell Therapy Basic Information
9.6.2 Lineage Cell Therapeutics Adoptive Cell Therapy Product Overview
9.6.3 Lineage Cell Therapeutics Adoptive Cell Therapy Product Market Performance
9.6.4 Lineage Cell Therapeutics Business Overview
9.6.5 Lineage Cell Therapeutics Recent Developments
9.7 BioTime
9.7.1 BioTime Adoptive Cell Therapy Basic Information
9.7.2 BioTime Adoptive Cell Therapy Product Overview
9.7.3 BioTime Adoptive Cell Therapy Product Market Performance
9.7.4 BioTime Business Overview
9.7.5 BioTime Recent Developments
9.8 Vericel Corporation
9.8.1 Vericel Corporation Adoptive Cell Therapy Basic Information
9.8.2 Vericel Corporation Adoptive Cell Therapy Product Overview
9.8.3 Vericel Corporation Adoptive Cell Therapy Product Market Performance
9.8.4 Vericel Corporation Business Overview
9.8.5 Vericel Corporation Recent Developments
9.9 Regeneus
9.9.1 Regeneus Adoptive Cell Therapy Basic Information
9.9.2 Regeneus Adoptive Cell Therapy Product Overview
9.9.3 Regeneus Adoptive Cell Therapy Product Market Performance
9.9.4 Regeneus Business Overview
9.9.5 Regeneus Recent Developments
9.10 Anhui Anke Biotechnology
9.10.1 Anhui Anke Biotechnology Adoptive Cell Therapy Basic Information
9.10.2 Anhui Anke Biotechnology Adoptive Cell Therapy Product Overview
9.10.3 Anhui Anke Biotechnology Adoptive Cell Therapy Product Market Performance
9.10.4 Anhui Anke Biotechnology Business Overview
9.10.5 Anhui Anke Biotechnology Recent Developments
9.11 Cellectis
9.11.1 Cellectis Adoptive Cell Therapy Basic Information
9.11.2 Cellectis Adoptive Cell Therapy Product Overview
9.11.3 Cellectis Adoptive Cell Therapy Product Market Performance
9.11.4 Cellectis Business Overview
9.11.5 Cellectis Recent Developments
9.12 NantKwest
9.12.1 NantKwest Adoptive Cell Therapy Basic Information
9.12.2 NantKwest Adoptive Cell Therapy Product Overview
9.12.3 NantKwest Adoptive Cell Therapy Product Market Performance
9.12.4 NantKwest Business Overview
9.12.5 NantKwest Recent Developments
9.13 SorrentoTherapeutics
9.13.1 SorrentoTherapeutics Adoptive Cell Therapy Basic Information
9.13.2 SorrentoTherapeutics Adoptive Cell Therapy Product Overview
9.13.3 SorrentoTherapeutics Adoptive Cell Therapy Product Market Performance
9.13.4 SorrentoTherapeutics Business Overview
9.13.5 SorrentoTherapeutics Recent Developments
9.14 Bellicum
9.14.1 Bellicum Adoptive Cell Therapy Basic Information
9.14.2 Bellicum Adoptive Cell Therapy Product Overview
9.14.3 Bellicum Adoptive Cell Therapy Product Market Performance
9.14.4 Bellicum Business Overview
9.14.5 Bellicum Recent Developments
10 Adoptive Cell Therapy Market Forecast by Region
10.1 Global Adoptive Cell Therapy Market Size Forecast
10.2 Global Adoptive Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adoptive Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Adoptive Cell Therapy Market Size Forecast by Region
10.2.4 South America Adoptive Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adoptive Cell Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adoptive Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adoptive Cell Therapy by Type (2025-2030)
11.1.2 Global Adoptive Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adoptive Cell Therapy by Type (2025-2030)
11.2 Global Adoptive Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Adoptive Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global Adoptive Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adoptive Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adoptive Cell Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Adoptive Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Adoptive Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Adoptive Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Therapy as of 2022)
Table 10. Global Market Adoptive Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Adoptive Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers Adoptive Cell Therapy Product Type
Table 13. Global Adoptive Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Adoptive Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Adoptive Cell Therapy Market Challenges
Table 22. Global Adoptive Cell Therapy Sales by Type (K Units)
Table 23. Global Adoptive Cell Therapy Market Size by Type (M USD)
Table 24. Global Adoptive Cell Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Adoptive Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Adoptive Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Adoptive Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global Adoptive Cell Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Adoptive Cell Therapy Sales (K Units) by Application
Table 30. Global Adoptive Cell Therapy Market Size by Application
Table 31. Global Adoptive Cell Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Adoptive Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Adoptive Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Adoptive Cell Therapy Market Share by Application (2019-2024)
Table 35. Global Adoptive Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Adoptive Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Adoptive Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Adoptive Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Adoptive Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Adoptive Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Adoptive Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Adoptive Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Novartis Adoptive Cell Therapy Basic Information
Table 44. Novartis Adoptive Cell Therapy Product Overview
Table 45. Novartis Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Adoptive Cell Therapy SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. Juno Adoptive Cell Therapy Basic Information
Table 50. Juno Adoptive Cell Therapy Product Overview
Table 51. Juno Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Juno Business Overview
Table 53. Juno Adoptive Cell Therapy SWOT Analysis
Table 54. Juno Recent Developments
Table 55. Kite Adoptive Cell Therapy Basic Information
Table 56. Kite Adoptive Cell Therapy Product Overview
Table 57. Kite Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Kite Adoptive Cell Therapy SWOT Analysis
Table 59. Kite Business Overview
Table 60. Kite Recent Developments
Table 61. Adaptimmune Adoptive Cell Therapy Basic Information
Table 62. Adaptimmune Adoptive Cell Therapy Product Overview
Table 63. Adaptimmune Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Adaptimmune Business Overview
Table 65. Adaptimmune Recent Developments
Table 66. Fibrocell Adoptive Cell Therapy Basic Information
Table 67. Fibrocell Adoptive Cell Therapy Product Overview
Table 68. Fibrocell Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Fibrocell Business Overview
Table 70. Fibrocell Recent Developments
Table 71. Lineage Cell Therapeutics Adoptive Cell Therapy Basic Information
Table 72. Lineage Cell Therapeutics Adoptive Cell Therapy Product Overview
Table 73. Lineage Cell Therapeutics Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lineage Cell Therapeutics Business Overview
Table 75. Lineage Cell Therapeutics Recent Developments
Table 76. BioTime Adoptive Cell Therapy Basic Information
Table 77. BioTime Adoptive Cell Therapy Product Overview
Table 78. BioTime Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. BioTime Business Overview
Table 80. BioTime Recent Developments
Table 81. Vericel Corporation Adoptive Cell Therapy Basic Information
Table 82. Vericel Corporation Adoptive Cell Therapy Product Overview
Table 83. Vericel Corporation Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Vericel Corporation Business Overview
Table 85. Vericel Corporation Recent Developments
Table 86. Regeneus Adoptive Cell Therapy Basic Information
Table 87. Regeneus Adoptive Cell Therapy Product Overview
Table 88. Regeneus Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Regeneus Business Overview
Table 90. Regeneus Recent Developments
Table 91. Anhui Anke Biotechnology Adoptive Cell Therapy Basic Information
Table 92. Anhui Anke Biotechnology Adoptive Cell Therapy Product Overview
Table 93. Anhui Anke Biotechnology Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Anhui Anke Biotechnology Business Overview
Table 95. Anhui Anke Biotechnology Recent Developments
Table 96. Cellectis Adoptive Cell Therapy Basic Information
Table 97. Cellectis Adoptive Cell Therapy Product Overview
Table 98. Cellectis Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Cellectis Business Overview
Table 100. Cellectis Recent Developments
Table 101. NantKwest Adoptive Cell Therapy Basic Information
Table 102. NantKwest Adoptive Cell Therapy Product Overview
Table 103. NantKwest Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. NantKwest Business Overview
Table 105. NantKwest Recent Developments
Table 106. SorrentoTherapeutics Adoptive Cell Therapy Basic Information
Table 107. SorrentoTherapeutics Adoptive Cell Therapy Product Overview
Table 108. SorrentoTherapeutics Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. SorrentoTherapeutics Business Overview
Table 110. SorrentoTherapeutics Recent Developments
Table 111. Bellicum Adoptive Cell Therapy Basic Information
Table 112. Bellicum Adoptive Cell Therapy Product Overview
Table 113. Bellicum Adoptive Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bellicum Business Overview
Table 115. Bellicum Recent Developments
Table 116. Global Adoptive Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Adoptive Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Adoptive Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Adoptive Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Adoptive Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Adoptive Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Adoptive Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Adoptive Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Adoptive Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Adoptive Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Adoptive Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Adoptive Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Adoptive Cell Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Adoptive Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Adoptive Cell Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Adoptive Cell Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Adoptive Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Adoptive Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adoptive Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global Adoptive Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Adoptive Cell Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adoptive Cell Therapy Market Size by Country (M USD)
Figure 11. Adoptive Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Adoptive Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. Adoptive Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Adoptive Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Adoptive Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Adoptive Cell Therapy Market Share by Type
Figure 18. Sales Market Share of Adoptive Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Adoptive Cell Therapy by Type in 2023
Figure 20. Market Size Share of Adoptive Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Adoptive Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Adoptive Cell Therapy Market Share by Application
Figure 24. Global Adoptive Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Adoptive Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global Adoptive Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global Adoptive Cell Therapy Market Share by Application in 2023
Figure 28. Global Adoptive Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Adoptive Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Adoptive Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Adoptive Cell Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Adoptive Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Adoptive Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Adoptive Cell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Adoptive Cell Therapy Sales Market Share by Region in 2023
Figure 44. China Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Adoptive Cell Therapy Sales and Growth Rate (K Units)
Figure 50. South America Adoptive Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Adoptive Cell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Adoptive Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Adoptive Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Adoptive Cell Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Adoptive Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Adoptive Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Adoptive Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Adoptive Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Adoptive Cell Therapy Market Share Forecast by Application (2025-2030)
